17 Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

被引：0
|
作者：
Haji, Ostad E. [1 ]
Mann, K. [1 ]
Dragicevic, A. [1 ]
Mueller, M. J. [2 ]
Boland, K. [3 ]
Rao, M. L. [3 ]
Fric, M. [4 ]
Laux, G. [4 ]
Hiemke, C. [1 ]
机构：
[1] Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, Mainz, Germany
[2] Psychiat Hosp Marburg & Giessen, Giessen, Germany
[3] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany
[4] Salzach Inn Klinikum, Kbo, Wasserburg, Germany
来源：
PHARMACOPSYCHIATRY | 2012年 / 45卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [21] Proactive therapeutic drug monitoring of adalimumab for pediatric Crohn's disease patients: A cost-effectiveness analysis
    Yao, Jiaqi
    Jiang, Xinchan
    You, Joyce H. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (09) : 2397 - 2407
  • [22] COST-EFFECTIVENESS ANALYSIS OF THERAPEUTIC DRUG MONITORING IN PEDIATRIC PATIENTS DIAGNOSED WITH STRUCTURAL-METABOLIC EPILEPSY
    Salih, M. R. M.
    Bahari, M. B.
    Shafie, A. A.
    Hassali, Ahmad M. A.
    Al-lela, O. Q. B.
    Abd, A. Y.
    Ganesan, V
    VALUE IN HEALTH, 2012, 15 (07) : A525 - A525
  • [23] Potential health impact and cost-effectiveness of drug therapy for prehypertension
    Tao, Chen
    Yu Dahai
    Cornelius, Victoria
    Rui, Qin
    Cai Yamei
    Jiang Zhixin
    Zhao Zhanzheng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 : 403 - 408
  • [24] Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
    Marquez-Megias, Silvia
    Nalda-Molina, Ricardo
    Sanz-Valero, Javier
    Mas-Serrano, Patricio
    Diaz-Gonzalez, Marcos
    Candela-Boix, Maria Remedios
    Ramon-Lopez, Amelia
    PHARMACEUTICS, 2022, 14 (05)
  • [25] Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial
    Gomez-Arango, Catalina
    Gorostiza, Inigo
    Ucar, Eduardo
    Garcia-Vivar, Maria Luz
    Perez, Clara Eugenia
    De Dios, Juan Ramon
    Alvarez, Belen
    Ruibal-Escribano, Ana
    Stoye, Claudia
    Vasques, Margarida
    Belzunegui, Joaquin
    Escobar, Antonio
    Trancho, Ziortza
    Ruiz del Agua, Ainhoa
    Del Rio, Lorena
    Jorquera, Cristina
    Diez, Eli
    Martinez, Antonio
    Nagore, Daniel
    RHEUMATOLOGY AND THERAPY, 2021, 8 (03) : 1323 - 1339
  • [26] Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial
    Catalina Gómez-Arango
    Inigo Gorostiza
    Eduardo Úcar
    Maria Luz García-Vivar
    Clara Eugenia Pérez
    Juan Ramon De Dios
    Belen Alvarez
    Ana Ruibal-Escribano
    Claudia Stoye
    Margarida Vasques
    Joaquin Belzunegui
    Antonio Escobar
    Ziortza Trancho
    Ainhoa Ruiz del Agua
    Lorena Del Rio
    Cristina Jorquera
    Eli Diez
    Antonio Martínez
    Daniel Nagore
    Rheumatology and Therapy, 2021, 8 : 1323 - 1339
  • [27] Cost-effectiveness of utilising proactive Infliximab therapeutic drug monitoring for inflammatory bowel disease in routine clinical practice
    Steen, J.
    McCormack, M.
    McShane, C.
    Healy, M.
    Crowley, V.
    Kennedy, U.
    Hayes, O.
    Dunne, C.
    Hartery, K.
    McKiernan, S.
    MacCarthy, F.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S307 - S308
  • [28] Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram
    Le Bloc'h, Y
    Woggon, B
    Weissenrieder, H
    Brawand-Amey, M
    Spagnoli, J
    Eap, CB
    Baumann, P
    THERAPEUTIC DRUG MONITORING, 2003, 25 (05) : 600 - 608
  • [29] Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort
    Negoescu, Diana M.
    Enns, Eva A.
    Swanhorst, Brooke
    Baumgartner, Bonnie
    Campbell, James P.
    Osterman, Mark T.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Vaughn, Byron P.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : 103 - 111
  • [30] Cost-effectiveness analysis of invasive EEG monitoring in drug-resistant epilepsy
    Kovacs, Sandor
    Toth, Marton
    Janszky, Jozsef
    Doczi, Tamas
    Fabo, Daniel
    Boncz, Imre
    Botz, Lajos
    Zemplenyi, Antal
    EPILEPSY & BEHAVIOR, 2021, 114
12345